July 11, 2025

Patients With Sludge Pancreatitis Have Fewer Complications

An international cohort study found that patients with sludge- or microlithiasis-induced acute pancreatitis had significantly fewer long-term complications than those with gallstone-related pancreatitis.

Conexiant

July 10, 2025

Tramadol Carries Lowest Constipation Risk Among Opioids

The UK hospital study of over 80,000 patients found that certain opioids, including morphine and oxycodone, carried a higher risk of severe constipation compared with others.

Conexiant

July 10, 2025

1 in 4 US Infants Missing Bifidobacterium: Study

Babies who lacked this key gut bacteria were at an increased risk of eczema, allergies, and asthma by age 2.

Conexiant

June 30, 2025

Can Typos Change a Diagnosis?

Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.

Conexiant

June 23, 2025

Higher SCFAs in Blood Predict Diabetes Risk

New research following Spanish adults over 7 years found that higher levels of specific gut-derived fatty acids in the blood—especially butyrate and isobutyrate—were linked to an increased risk of developing type 2 diabetes, offering insights into early risk prediction.

Conexiant

June 23, 2025

Fidaxomicin Effective, Well-Tolerated in Pediatric CDI

A multicenter study of pediatric patients treated with fidaxomicin for C difficile found over half were cured by two weeks, and only one in five had a recurrence within two months.

Conexiant

June 20, 2025

Gut Bacteria Predict Chemotherapy-Related Heart Damage

Specific gut bacteria correlate with biomarkers indicating increased risk of cardiotoxicity in breast cancer patients before chemotherapy treatment.

Conexiant

June 17, 2025

FMT as First-Line CDI Treatment?

New randomized trial shows fecal microbiota transplantation may reduce antibiotic dependence in first-episode infections

Conexiant

November 12, 2024

Gut Bacteria Linked to Insulin Resistance

Study highlights how 'Proteobacteria and bile acids in the gut negatively impact insulin sensitivity,' offering potential therapeutic targets across the microbiome-gut-adipose-liver axis.

Conexiant